The OGF-OGFr Axis Utilizes the P21 Pathway to Restrict Progression of Human Pancreatic Cancer

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-7-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression

PLoS ONE
Multidisciplinary
2009English

miR‑320/ELF3 Axis Inhibits the Progression of Breast Cancer via the PI3K/AKT Pathway

Oncology Letters
Cancer ResearchOncology
2020English

Targeting the Hypoxia Pathway to Treat Pancreatic cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Loss of HNF6 Expression Correlates With Human Pancreatic Cancer Progression

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2014English

LincRNA-p21 Enhances the Sensitivity of Radiotherapy for Human Colorectal Cancer by Targeting the WNT/Β-Catenin Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2014English

Rhein Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

The Distinct Role of CD73 in the Progression of Pancreatic Cancer

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2019English

Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway

Cancer Management and Research
Oncology
2019English

ANLN-induced EZH2 Upregulation Promotes Pancreatic Cancer Progression by Mediating miR-218-5p/LASP1 Signaling Axis

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy